[New cytostatic drugs. Status: 1986]. / Neue Zytostatika. Stand: 1986.
Onkologie
; 10(4): 226-31, 1987 Aug.
Article
in De
| MEDLINE
| ID: mdl-3313146
ABSTRACT
In oncology phase-II studies are planned for testing antitumor activity in a series of malignant tumors. Most important is the development of drugs from entirely new classes of chemicals, fermentation products etc. Clinical research with analogues of known cytotoxic drugs aims at broader spectra of activity and at decreased toxicity in an attempt to avoid, for example, the cardiac toxicity of the anthracyclines or the renal and gastrointestinal toxicities of cis-platinum.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neoplasms
/
Antineoplastic Agents
Limits:
Humans
Language:
De
Journal:
Onkologie
Year:
1987
Document type:
Article